3B BlackBio Dx Ltd (3BBLACKBIO.BO) Comparison with companies in other sectors?

3B BlackBio Dx Ltd has a share price of 8.58M. You can analyze 3B BlackBio Dx Ltd (3BBLACKBIO.BO) competitors across different market sectors through stock heatmaps.

What are 3BBLACKBIO.BO's NET and operating margins?

3B BlackBio Dx Ltd (3BBLACKBIO.BO) operating margin is around N/A, and net profit margin is approximately N/A as of the latest reports.

In what way does 3BBLACKBIO.BO's earnings per share (EPS) trend reflect its financial momentum?

3B BlackBio Dx Ltd (3BBLACKBIO.BO) EPS is 66.46 (If EPS value is positive, then "signals consistent profit growth" if Negative then "signals consistent loss"). This metric is also critical in assessing valuation metrics like the P/E ratio for 3B BlackBio Dx Ltd is 18.49, and the company's ability to reinvest or distribute profits.

What does a high ROE mean for 3B BlackBio Dx Ltd?

A high ROE suggests efficient use of shareholder equity to generate profit. It often signals strong management and profitability.

How do I know if AAPL is overvalued or undervalued?

Check valuation ratios for 3B BlackBio Dx Ltd like P/E which is N/A, P/B which is N/A, and PEG which is N/A. Compare them with sector averages to evaluate if the stock is priced fairly.

3B BlackBio Dx Ltd

Get $10 bonus on your first $100 deposit for 3BBLACKBIO.BO

3BBLACKBIO.BO•BSE

Healthcare

Biotechnology

Get $10 bonus on your first $100 deposit for 3BBLACKBIO.BO

₹1228.55

₹74.15(6.42%)

Indian Market opens in 34h 46m

3B BlackBio Dx Ltd Fundamental Analysis

3B BlackBio Dx Ltd (3BBLACKBIO.BO) shows weak financial fundamentals with a PE ratio of 18.49, profit margin of N/A, and ROE of N/A. The company generates N/A in annual revenue with N/A year-over-year growth of N/A.

Key Strengths

No significant strengths identified.

Areas of Concern

No major concerns flagged.

We analyze 3BBLACKBIO.BO's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of 0.0/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.

Fundamental Health Score

0.0/100

We analyze 3BBLACKBIO.BO's fundamental strength across five key dimensions:

Efficiency Score

Weak

3BBLACKBIO.BO struggles to generate sufficient returns from assets.

ROA > 10%

N/A

Valuation Score

Moderate

3BBLACKBIO.BO shows balanced valuation metrics.

PE < 25

18.49

PEG Ratio < 2

N/A

Growth Score

Moderate

3BBLACKBIO.BO shows steady but slowing expansion.

Revenue Growth > 5%

N/A

EPS Growth > 10%

N/A

Financial Health Score

Weak

3BBLACKBIO.BO carries high financial risk with limited liquidity.

Debt/Equity < 1

N/A

Current Ratio > 1

N/A

Profitability Score

Weak

3BBLACKBIO.BO struggles to sustain strong margins.

ROE > 15%

N/A

Net Margin ≥ 15%

N/A

Positive Free Cash Flow

N/A

Key Financial Metrics

Is 3BBLACKBIO.BO Expensive or Cheap?

P/E Ratio

3BBLACKBIO.BO trades at 18.49 times earnings. This indicates a fair valuation.

18.49

How Well Does 3BBLACKBIO.BO Make Money?

No data available.

Following the Money - Real Cash Generation

No data available.

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

N/A

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

N/A

vs 25 benchmark

P/B Ratio

Price to book value ratio

N/A

vs 25 benchmark

P/S Ratio

Price to sales ratio

N/A

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

N/A

vs 25 benchmark

Current Ratio

Current assets to current liabilities

N/A

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

N/A

vs 25 benchmark

ROA

Return on assets percentage

N/A

vs 25 benchmark

ROCE

Return on capital employed

N/A

vs 25 benchmark

How 3BBLACKBIO.BO Stacks Against Its Sector Peers

Metric	3BBLACKBIO.BO Value	Sector Average	Performance
P/E Ratio	N/A	28.45	N/A
ROE	N/A	763.00%	N/A
Net Margin	N/A	-45265.00% (disorted)	N/A
Debt/Equity	N/A	0.34	N/A
Current Ratio	N/A	2795.60	N/A
ROA	N/A	-16588.00% (disorted)	N/A

Historical Growth Performance

5-Year Growth Trajectory

This section reviews 3B BlackBio Dx Ltd's 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

N/A

Industry Style: Defensive, Growth, Innovation

EPS CAGR

N/A

Industry Style: Defensive, Growth, Innovation

FCF CAGR

N/A

Industry Style: Defensive, Growth, Innovation

3B BlackBio Dx Ltd Fundamental Analysis

Key Strengths

Areas of Concern

Fundamental Health Score

Efficiency Score

Valuation Score

Growth Score

Financial Health Score

Profitability Score

Key Financial Metrics

Is 3BBLACKBIO.BO Expensive or Cheap?

How Well Does 3BBLACKBIO.BO Make Money?

Following the Money - Real Cash Generation

Financial Ratios Analysis

Valuation Ratios

Financial Health

Efficiency Ratios

How 3BBLACKBIO.BO Stacks Against Its Sector Peers

Historical Growth Performance

5-Year Growth Trajectory

Fundamental Analysis FAQ

3B BlackBio Dx Ltd (3BBLACKBIO.BO) Comparison with companies in other sectors?

What are 3BBLACKBIO.BO's NET and operating margins?

In what way does 3BBLACKBIO.BO's earnings per share (EPS) trend reflect its financial momentum?

What does a high ROE mean for 3B BlackBio Dx Ltd?

How do I know if AAPL is overvalued or undervalued?